10 Best Life Sciences Stocks To Own Right Now

10 Best Life Sciences Stocks To Own Right Now: E2open Inc (EOPN)

E2open, Inc., incorporated in September 2003, is a provider of cloud-based, on-demand software solutions. The Company's software applications allow network participants to input, access and share data and execute business processes across internal operating units and external entities. Its E2open Business Network supports operational business processes of its customers and their trading partners, including supply chain management, procurement, sales and finance functions. The E2open Business Network enables integrated planning and execution across trading partner networks. The Company offers on-demand software solutions, which enable its customers to have constant access to its solutions.

The Company houses the hardware and software in third-party facilities, and provides its customers with access to the software applications, along with data security and storage, backup, and recovery services. It invoices its customers for subscription and support in advanc e for annual use of its software solutions. The Company's professional services revenue is primarily derived from fees for enabling services, such as solution consulting, solution deployment, B2B on-boarding and solution support that help its customers deploy, manage and support our solutions. These services are sold in conjunction with the sale of its on-demand software solutions or on a standalone basis. It provides professional services both on a fixed fee and a time and materials basis, and invoices its customers in advance, monthly, or upon reaching project milestones.

The Company competes with Infor, Oracle, SAP, GXS Corporation, IBM/Sterling Commerce, SPS Commerce and JDA Software Group, Inc.

Advisors' Opinion:

• [By Evan Niu, CFA]

  What: Shares of E2open (NASDAQ: EOPN  ) have plunged today by as much as! 28% after the company reported fourth-quarter results.

  So what: Non-GAAP revenue in the fourth quarter totaled $18.1 million, shy of the $19.7 million in adjusted sales that investors were expecting. The bottom line also registered a miss, with the adjusted loss of $0.06 coming in below the consensus estimate of a $0.05 per share non-GAAP net loss. CEO Mark Woodward's comments about the company adding a record number of new customers in the quarter didn't make investors feel any better.

• [By Monica Gerson]

  E2open (NASDAQ: EOPN) is projected to post a Q2 loss at $0.15 per share on revenue of $17.23 million.

  Bank of the Ozarks (NASDAQ: OZRK) is expected to post its Q3 earnings at $0.60 per share on revenue of $69.57 million.

• [By The GeoTeam]

  Our recent 2013 articles on SaaS companies Selectica (SLTC), E2open (EOPN), Responsys (MKTG), Vocus (VOCS), and ExactTarget (ET) highlighted such opportunities. The average return since the inception of our coverage currently stands at around 34% (55% at their highs).

source from Top Stocks Blog:http://www.topstocksblog.com/10-best-life-sciences-stocks-to-own-right-now.html